24 September, 2024
0 Comments
1 category
medicine
Monday, 23 September 2024
Seoul – Treatment with an SGLT2 inhibitor could protect patients with type 2 diabetes from degenerative brain diseases. This emerged in a population-based cohort study from South Korea, which has now been published in Neurology (2024; DOI: 10.1212/WNL.0000000000209805). Type 2 diabetes is a known risk factor for neurodegenerative diseases. A treatment that normalizes blood sugar could therefore be a…
#SGLT2 #inhibitors #protect #dementia #Parkinsons
Category: Medical Encyclopedia